Top MoCA Cognition Alternatives

Creyos Health is a reliable platform that has undergone scientific validation and is endorsed by clinicians, providing an intuitive experience for patients by merging unique online tasks with electronic behavioral health assessments. This all-encompassing solution, substantiated by research, empowers healthcare professionals to detect cognitive deficits and behavioral health concerns with adaptability, engagement, precise measurements, and potential reimbursement eligibility. Backed by over thirty years of scientific investigation, Creyos has been referenced in more than 400 peer-reviewed publications. Currently, over 10,000 healthcare providers depend on Creyos to evaluate their patients' cognitive and behavioral well-being. The platform features a suite of 12 online cognitive tasks, each taking only 2-3 minutes to finish, specifically designed to uncover even the slightest cognitive impairments. These tasks assess key areas including short-term memory, reasoning abilities, attention span, and verbal skills. Furthermore, the platform includes digitized behavioral health evaluations that swiftly compute results, providing healthcare professionals with quick insights. This streamlined process not only enhances the efficiency of assessments but also facilitates prompt interventions that can greatly improve patient outcomes. Ultimately, Creyos Health represents a significant advancement in the integration of technology and behavioral health assessment.

Cognistat is recognized as a leading tool for cognitive assessment, focusing on five essential domains of cognitive function: language, spatial reasoning, memory, calculations, and logical reasoning. Originating from Stanford University, this standardized tool is suitable for a wide demographic, including adolescents, adults, and seniors aged 60 to 84, thus ensuring its versatility in application. It is intended to be administered by trained healthcare professionals, ensuring accurate and reliable results. In addition, Cognistat has undergone cultural adaptations and validations in multiple languages through collaborations with respected universities and global partners. The effectiveness of this tool is supported by more than 400 peer-reviewed studies, demonstrating its utility in evaluating conditions such as stroke, dementia, traumatic brain injuries, psychiatric disorders, and substance abuse. Retaining the beneficial characteristics of its original paper-and-pencil format, the Cognistat Assessment System delivers a quick yet comprehensive cognitive evaluation using both screening and metric methodologies. This combination of speed and thoroughness renders it an indispensable resource in numerous clinical environments, significantly improving the assessment process across a variety of patient populations. Overall, Cognistat’s robust design and empirical backing make it an essential instrument in the field of cognitive evaluation.

CogniFit is a leading provider of tailored online cognitive training solutions designed to assess and enhance various cognitive skills across all age groups. Their scientifically-supported platform offers over 60 engaging games and mental exercises that target improvements in memory, attention, reasoning, and coordination. Users can begin with a free evaluation that reveals their cognitive strengths and weaknesses, followed by access to personalized training programs designed to strengthen specific cognitive functions. The tools provided by CogniFit are advantageous not only for those seeking to improve their mental abilities but also for professionals in sectors such as healthcare, education, and research, who employ these resources to promote cognitive advancement and recovery. You can monitor your cognitive progress with daily and weekly score updates, establish attainable goals to raise your scores through regular brain training sessions, and devise a structured plan to practice as often as necessary to reach your targets. This holistic approach empowers users to take an active role in their cognitive development journey, making it a comprehensive resource for both personal and professional growth. Ultimately, CogniFit fosters an environment where users can effectively work towards enhancing their mental agility and overall cognitive health.

The Cambridge Neuropsychological Test Automated Battery (CANTAB), developed at the University of Cambridge, offers precise and objective evaluations of cognitive functions tied to neural systems. This comprehensive battery is adept at identifying differences in neuropsychological performance, featuring a diverse range of assessments that measure working memory, learning capabilities, executive functions, as well as various types of memory—including visual, verbal, and episodic—along with attention, information processing speed, and reaction times. Additionally, it evaluates social and emotional recognition, decision-making processes, and response inhibition. Such cognitive assessments are essential tools in deciphering the intricate workings of specific brain functions related to multiple disorders, providing significant insight into their root causes, enabling the early identification of symptoms, and measuring the effectiveness of interventions aimed at improving neurological health. Employing CANTAB allows researchers and clinicians to gain deeper insights into cognitive deficits, ultimately paving the way for more tailored and efficient treatment strategies and support mechanisms that cater to individual needs. This approach can significantly enhance our understanding of cognitive health and its impact on overall well-being.

BrainFx provides interactive digital cognitive evaluations that are crafted to uncover neurofunctional elements that might be neglected by conventional tests, allowing healthcare providers to gain a more comprehensive view of an individual's cognitive health. These evaluations swiftly reveal mild to moderate dysfunctions and deliver critical insights for creating bespoke treatment strategies rooted in real-world, context-sensitive activities. Employing an innovative Neurofunctional framework, BrainFx assesses cognitive function by examining not just cognitive capabilities, but also the impacts of psychosocial and physical well-being, alongside environmental and task-specific elements that can sway cognitive performance. This thorough approach ensures that BrainFx's evaluations resonate more closely with everyday challenges, making them not only more captivating but also more proficient at identifying issues that traditional assessments might overlook. Consequently, these evaluations grant a well-rounded perspective on cognitive function, empowering health professionals to consider a broader range of factors in their treatment plans. By revolutionizing the methodology of cognitive assessments, BrainFx is paving the way for enhanced patient outcomes and fostering a deeper understanding of cognitive health management. Ultimately, this advancement signifies a significant leap forward in the assessment and treatment of cognitive health issues.

CAMCI-Research represents a flexible suite of computerized evaluations designed to assess cognitive functions. This self-directed, digital instrument allows researchers to tailor task protocols specifically for collecting data related to accuracy and response times, facilitating comparisons with established normative values. The complete CAMCI-Research package includes nine distinct behavioral tasks that target various cognitive areas, such as attention, memory (which includes verbal, non-verbal, functional, and incidental types), executive functioning, and processing speed. In addition to these tasks, participants can complete a series of self-report questionnaires that gather information on factors potentially affecting their performance, like perceived cognitive decline, alcohol use, depressive symptoms, and anxiety levels. A notable aspect of this assessment tool is its virtual environment task, which investigates areas like incidental memory that are often difficult to capture through conventional paper-based approaches. By utilizing computer-based assessments, the tool ensures consistent administration and scoring, significantly reducing variability that may occur due to differences among examiners or testing locations. Consequently, researchers can trust in the dependability and consistency of the outcomes derived from this all-encompassing evaluation method, making it an invaluable asset in cognitive research. Ultimately, CAMCI-Research not only enriches the understanding of cognitive abilities but also adapts to the evolving needs of contemporary research.

The Herrmann Brain Dominance Instrument (HBDI) is an extensive survey comprised of 116 questions that efficiently assesses cognitive preferences through four interconnected systems reflecting the brain's quadrants. Developed by Ned Herrmann during his tenure in management education at General Electric, this tool aims to uncover how thought processes influence growth in management and leadership roles. Unlike conventional assessments that focus on behavioral traits or personality, the HBDI provides a distinctive insight into an individual's mental inclinations, which ultimately affect their approaches to problem-solving and decision-making. It is essential to note that the HBDI does not gauge one's abilities, skills, or particular cognitive functionalities, nor does it assess activity in specific brain areas. With a user base exceeding 4 million people across over 60 nations and offered in 16 languages, the HBDI has become an indispensable asset for organizations aiming to utilize cognitive diversity effectively. This broad adoption highlights the critical need for understanding different thinking styles, which can significantly enhance collaboration and foster innovation within teams. Recognizing and valuing these diverse cognitive preferences can lead to more effective leadership strategies and improved organizational outcomes.

Lumosity is a brain training program designed to enhance cognitive functions such as memory, mental agility, and various other skills through engaging games. By transforming scientific experiments from research into interactive activities, the platform aims to boost cognitive abilities, including memory retention, speed of thought, and analytical thinking. Users receive personalized feedback and insights about their cognitive performance, with fresh and challenging games presented daily to keep their interest alive. The experience is tailored to each user’s unique strengths and areas that need improvement, creating an individualized learning experience. Featuring a vast collection of over 50 games crafted by specialists in neuroscience and game development, Lumosity targets essential cognitive domains such as speed, memory, attention, flexibility, language, problem-solving, and mathematics. With more than 100 million users worldwide, its broad appeal is evident. Furthermore, a randomized study conducted by Lumos Labs indicated that participants who engaged with Lumosity for 10 weeks showed significant improvements in various cognitive tests compared to a control group, particularly excelling in working memory and fluid reasoning, thereby highlighting the potential effectiveness of the program for brain training. This suggests that regular participation in such cognitive games may lead to measurable enhancements in cognitive skills over time.

HappyNeuron serves as a cutting-edge digital platform designed for cognitive therapy, aimed at aiding healthcare professionals in providing cognitive rehabilitation, stimulation, and remediation. It boasts a growing collection of 45 customizable exercises that target various cognitive functions, including executive function, memory, language skills, attention, visual-spatial abilities, processing speed, and auditory processing, with the flexibility to adapt to the unique needs of each patient. Clinicians can utilize printable worksheets that complement therapy with evidence-based materials, enhancing the overall treatment experience. The Pro version of HappyNeuron offers advanced features like automatic tracking and reporting of patient progress, simplifying the assessment of improvements for healthcare providers. Additionally, the platform supports multiple languages, ensuring that patients can receive therapy in their language of choice. By allowing clinicians to assign home exercises to patients, HappyNeuron increases the frequency and intensity of therapeutic activities, which may contribute to better cognitive health outcomes and heightened patient engagement. Consequently, HappyNeuron not only improves the effectiveness of therapy but also encourages patients to actively participate in their cognitive rehabilitation process, fostering a sense of ownership over their recovery journey. This active participation can significantly motivate patients to adhere to their rehabilitation plans, ultimately enhancing their overall progress.

SilverCloud, developed by Amwell, is an all-encompassing digital platform aimed at mental health, offering over 30 distinct online behavioral health programs that address a variety of issues, including anxiety, depression, stress, and chronic conditions. These interactive programs are built on evidence-based practices, designed to empower individuals to take charge of their mental well-being through personalized content, engaging tools, and supportive strategies. Accessible on smartphones, tablets, and computers, SilverCloud provides a flexible and confidential way for users to engage with mental health resources at their own pace and convenience. It has gained recognition from numerous health systems, employers, health plans, and educational institutions for its effectiveness in delivering widespread support. Studies indicate that nearly 80% of users report a decrease in symptoms associated with anxiety and depression after utilizing SilverCloud's resources. In addition, the platform offers specialized programs catering to families, substance use disorders, and other specific requirements, showcasing its adaptability in addressing a wide range of mental health issues. Overall, SilverCloud exemplifies a crucial leap forward in the availability and efficacy of mental health services, making it an invaluable resource for those seeking help. As society continues to recognize the importance of mental health, platforms like SilverCloud play an essential role in fostering awareness and providing necessary support.

Herrmann's Whole Brain Thinking offers a research-based framework that recognizes and leverages the varied cognitive styles found in individuals, teams, and organizations. By understanding their unique thinking preferences, people can more effectively pinpoint areas for improvement, enhance collaboration, and move closer to their goals. The practice of Whole Brain Thinking leads to increased focus, productivity, and teamwork, creating a harmonious environment that maximizes each person's contributions. Additionally, it reduces counterproductive conflicts and minimizes the chances of groupthink by allowing leaders and team members to utilize the diverse cognitive styles present, enabling quick recognition of challenges and adaptability in fast-paced settings. This approach not only strengthens communication but also speeds up knowledge sharing through easy-to-implement strategies, equipping teams to apply Whole Brain Thinking principles to address real challenges in the workplace efficiently. Furthermore, it nurtures a culture of innovation and flexibility within the organization, paving the way for sustained growth and improvement. Such a dynamic framework ultimately empowers teams to thrive in an ever-evolving business landscape.

Cognigram is a web-based tool that automatically evaluates data and generates comprehensive reports summarizing the results of cognitive assessments. The assessment typically takes between 10 to 15 minutes to complete. This platform is designed to assist healthcare providers by offering an impartial review of cognitive abilities for individuals aged 6 to 99. Clinicians receive user-friendly reports that include comparisons to normative data from healthy individuals of similar age. The evaluation process lasts approximately 15 minutes and assesses four separate cognitive domains. Results are calculated automatically to enhance efficiency, and the assessment features four tests that use playing cards to present simple "yes" or "no" questions, with clear instructions and practice sessions included for better understanding. In addition, the Cognigram system is not only suitable for a single assessment but also for tracking cognitive changes over time through multiple evaluations, proving to be a flexible and valuable resource in cognitive assessment. This dual functionality allows for ongoing monitoring, making it an essential asset for healthcare professionals dedicated to understanding cognitive health.

Cognitive Apps offers a cutting-edge AI-powered API that effortlessly incorporates mental health analytics into a diverse range of products and services. By analyzing users' voice or text communications, this API effectively discerns emotions, moods, and mental health conditions, delivering essential insights like overall mood evaluations, emotion detection, and monitoring of mental health issues. With a remarkable accuracy of 87%, the system only requires a quick 5-second voice sample to perform rapid emotion analysis. This adaptable technology serves various industries by enhancing application functionalities, customizing user interactions, and improving user experience through real-time emotion recognition. Additionally, the API processes data from voice recordings, text exchanges, and physical health indicators, offering a comprehensive perspective on mental health that enriches customer insights and cultivates individualized user experiences. Furthermore, by utilizing this groundbreaking methodology, companies can obtain profound understandings of user behaviors and preferences, leading to enhanced engagement and increased customer satisfaction. Ultimately, the integration of Cognitive Apps' API can transform how businesses connect with their audience, positioning them at the forefront of mental health support and user experience optimization.

Cognassist operates as a dedicated platform centered around neuro-inclusion, with the objective of empowering individuals with varying cognitive profiles to achieve success. We assist organizations in their daily efforts towards neuro-inclusion by providing top-tier cognitive diversity assessments along with specialized training focused on neurodiversity. Our offerings not only promote the growth of employees but also help businesses comply with legal and ethical standards. Through our accredited training programs, we equip teams with essential knowledge and skills that enhance their overall effectiveness. Our clinically validated cognitive mapping facilitates customized workplace adjustments while respecting different preferences for sharing personal information. The neuro-difference dashboard improves the visibility of neurodiversity within organizations, nurturing a more inclusive atmosphere. For educational institutions, we play a vital role in identifying the distinct needs of students, personalizing their learning experiences, lowering costs, ensuring compliance with Ofsted standards, and boosting overall academic results. Our efficient digital cognitive assessments can identify learner needs in just 30 minutes, streamlining the process of addressing individual obstacles and supporting varied educational paths. By fostering understanding and appreciation of cognitive differences, we strive to create a society where every unique cognitive profile is recognized and utilized for collective success. Ultimately, our vision encompasses a world where the potential of every individual is harnessed, leading to greater innovation and productivity.

The Do-IT Profiler is a digital platform dedicated to evaluating and identifying neurodiversity, aiding both individuals and organizations in understanding the strengths and challenges associated with different neurodivergent conditions such as ADHD, dyslexia, autism, dyscalculia, and dyspraxia. It offers tailored profilers for distinct scenarios, including the Neurodiversity Profiler + for adults eager to explore their cognitive profiles, the Neurodiversity Workplace Profiler designed for employees aiming to improve their performance, and the Children's Profiler aimed at parents or guardians of children aged 7 to 16. Each profiler produces a personalized report that delivers customized recommendations, practical support tools, and resources meant to capitalize on strengths while effectively managing challenges. In addition to these profiling services, Do-IT Profiler also presents neurodiversity training courses and consultancy services that promote inclusivity and improve the overall well-being of individuals within various organizations. This platform ultimately acts as a vital resource for anyone striving to understand and navigate the intricacies of neurodiversity across different life domains, making it an essential tool for fostering acceptance and support in society.

Dystech, an Australian company, is dedicated to improving the way reading assessments and dyslexia screenings are conducted through innovative, AI-driven solutions. Their platform, Dyscover, allows for online evaluations covering a variety of reading elements such as phonics, fluency, and phonological awareness, making it suitable for both in-person and remote settings. This resource is widely adopted by professionals including speech pathologists, educators, teaching assistants, and tutors who work with children aged five and older. After each assessment, Dyscover promptly produces comprehensive reports, eliminating the need for manual grading and fostering a data-informed approach to literacy interventions. In addition, the AI assistant Dystutor offers customized recommendations and lesson plans tailored to the assessment results, helping educators address the unique needs of their students. Dystech's mission is to transform the accessibility and effectiveness of reading assessments, ultimately aiming to improve literacy outcomes for learners. By harnessing advanced technology, they are reshaping the educational support landscape for individuals facing reading difficulties, ensuring that every child has the opportunity to succeed in their learning journey. Their commitment to innovation positions them as leaders in the field of educational technology.

CNS Vital Signs leads the way in developing innovative tools and technologies aimed at assessing neurocognitive and behavioral health. We provide healthcare professionals and researchers with advanced technology that significantly improves their capacity to evaluate and manage conditions related to neurocognitive and behavioral health. Our extensive platform includes a variety of computerized tests that are designed to assess, monitor, and address different issues pertaining to neurocognitive and behavioral well-being. Clinicians depend on CNS Vital Signs for a rapid and effective evaluation of a patient's cognitive abilities. This assessment tool is well-respected in the medical community and is frequently covered by insurance, making it a popular option for patients facing neurocognitive or behavioral difficulties. With a network of over 10,000 clinicians and researchers spanning 52 countries, CNS Vital Signs is highly esteemed within the field. Our platform not only caters to hospitals and healthcare providers but also enables researchers to deepen their understanding of neurocognitive disorders, ultimately contributing to improved patient outcomes and quality of care. Thus, CNS Vital Signs is committed to bridging the gap between research and practical application in the realm of cognitive health assessment.

InCrowd Interview represents a groundbreaking approach to qualitative research, utilizing advanced technology to facilitate rapid and cost-effective inquiries that engage a wider range of healthcare professionals. The platform allows for scheduling interviews on the same day, drastically reducing the time it takes to complete projects that would normally span weeks or more to just a few days. This innovative methodology involves sourcing verified participants from a specialized panel, managing expert interviews, recording those discussions, and securely archiving both the recordings and transcripts within the platform. By enhancing accessibility, it delivers a seamless experience that eliminates obstacles for healthcare professionals and simplifies the interaction process for both researchers and HCPs. The streamlined nature of the technology further refines the workflow by automating the processes of identifying participants, sending out invitations, and coordinating schedules for both participants and moderators, all conducted through a single, cohesive system. Additionally, the platform is designed with compliance in mind, fostering effective communication and ensuring secure storage of all transcripts in a way that allows researchers to concentrate on extracting valuable insights without the burden of data management concerns. In essence, InCrowd Interview is revolutionizing the landscape of qualitative research, prioritizing efficiency and user-friendliness while paving the way for deeper engagement in healthcare research initiatives. Its ability to adapt to the needs of researchers and healthcare professionals alike is what truly sets it apart in the field.

Navigate360 provides a comprehensive suite of solutions centered on wellness, preparedness, intervention, and prevention, enabling communities to thrive and remain secure. By offering clear data alongside a seamless integration of threat detection and prevention tools, as well as resources focused on mental health and overall wellness, Navigate360 addresses critical societal challenges, such as violence in schools, workplaces, places of worship, and other shared spaces. Our proactive approach to mental health and concerning behaviors aims to mitigate the rising incidents of violence that are becoming increasingly common. Our goal is to cultivate a culture of safety that not only protects lives but also enriches them. We are trusted by educational institutions, workplaces, healthcare organizations, and diverse communities, working hand in hand with local law enforcement and first responders. Discover how our innovative solutions can empower your community to not only endure but also flourish in a safer environment. Together, we can build a brighter future where safety and wellness are fundamental priorities for everyone involved, ensuring that every community member feels secure and supported.

GL Assessment is recognized as the leading provider of formative assessments used by schools across the UK and Ireland. Their extensive data highlights both the strengths and weaknesses in essential subjects like reading, identifies barriers to learning, and supports children with special educational needs. In addition, they offer insights into student progress, aid in overall school enhancement, and influence teaching practices. With a trusted history of over 40 years, they have conducted more than 30 million online assessments in more than 100 countries worldwide. Their standardized assessments undergo rigorous validation and are trusted in over 100 nations. They also provide tailored reports for various stakeholders, which fosters productive discussions among key individuals. Their assessment range includes categories such as baselining, attainment, literacy and language, numeracy, special educational needs, wellbeing, and health and psychology. This extensive range ensures that schools are well-equipped to meet the varied needs of their students, fostering a nurturing educational atmosphere. Ultimately, GL Assessment's commitment to adaptability and support plays a crucial role in enhancing the overall educational experience for learners.

Auticon provides an in-depth Neurodiversity Inclusion Maturity Assessment designed to help organizations evaluate their neuroinclusion status and identify areas for improvement. Utilizing a distinctive cloud-based platform, the assessment delves into various aspects of the employee experience, including recruitment, onboarding, training, and retention, establishing a solid foundation while offering data-driven insights. The assessment methodology incorporates live interviews, two anonymous surveys, and a review of existing organizational documentation to assess the current support structures available for neurodivergent employees. Once the data collection is complete, Auticon delivers a detailed report highlighting both strengths and weaknesses, facilitates an engaging workshop to discuss the findings, and collaborates with stakeholders to develop a tailored strategy for advancing neuro inclusion initiatives. This structured approach not only encourages the enactment of impactful changes but also nurtures a workplace environment that appreciates diversity and encourages collaboration among all team members. By committing to these initiatives, organizations can greatly improve their capacity to support neurodivergent individuals, ultimately fostering a more inclusive and understanding workplace culture. Embracing neurodiversity can lead to innovative solutions and perspectives that benefit the entire organization.

BrainSightAI stands at the forefront of health technology, leveraging artificial intelligence and machine learning to revolutionize the field of brain mapping via AI-driven connectomics, which facilitates the creation of customized brain maps. The VoxelBox product line utilizes these advanced AI methodologies to generate personalized brain maps, aimed at refining pre-surgical planning and enhancing outcomes for patients grappling with brain tumors and various neurological challenges. Additionally, BrainSightAI collaborates with leading hospitals nationwide to conduct clinical trials focused on a spectrum of brain-related ailments, including Alzheimer's disease, brain tumors, psychiatric disorders, Parkinson's disease, and stroke. Our primary mission is to advance brain science while enriching the lives of individuals through innovative tools that enhance our comprehension of the human brain. By working closely with healthcare professionals, we aspire to make a meaningful contribution to neurology and the overall quality of patient care, ultimately setting new standards in medical practice. Through our efforts, we hope to foster a brighter future for those affected by neurological conditions.

Atlantis Health offers a wide range of strategic services and multichannel solutions tailored for the pharmaceutical, biotech, and healthcare industries, with a strong focus on understanding patient journeys, deriving behavioral insights, and developing evidence-based patient engagement initiatives. Their approach blends behavioral science with a collaborative effort from specialists across various disciplines—strategy, content development, creative design, technical support, and service delivery—to utilize effective strategies that boost engagement and foster beneficial changes in health behaviors. Their multichannel services include the development of educational content related to health and behavior modification, as well as digital engagement platforms that feature web interfaces, mobile applications, email communication, SMS, and digital coaching, in addition to motivational coaching designed to enhance self-management abilities. Moreover, they offer at-home support services that consist of medication administration and training provided by registered nurses, along with ensuring that medications, educational materials, and necessary tools are delivered directly to patients' homes. By adopting this comprehensive methodology, Atlantis Health aims to empower individuals on their health journeys while fostering cooperation among various healthcare stakeholders and enhancing the overall effectiveness of health interventions. This commitment to patient-centric care represents a significant step forward in improving health outcomes across the board.

The Thomas talent assessment platform merges machine learning with psychological insights to enhance hiring and development strategies. This innovative tool equips you to make more informed decisions about candidates, allowing you to foresee who will thrive in both their role and within your organization. Traditional tools like LinkedIn profiles and resumes often fail to reveal the true potential of applicants, and relying solely on intuition is insufficient. The Thomas Talent Assessment Platform fills this gap, providing deep insights into the personality, aptitude, and behavior of your ideal candidate. You can swiftly generate candidate profiles aligned with the specific role and desired traits. Utilizing star ratings helps minimize unconscious bias, forecast performance, and facilitates direct comparisons between candidates. Furthermore, it offers personalized onboarding advice to ensure that new employees begin their journey on the right foot, setting them up for success from day one. This comprehensive approach not only streamlines the hiring process but also fosters a more effective and cohesive workplace culture.

Our collection of educational resources and assessment tools, in combination with our diverse offerings, is designed to empower learners across all levels to seize new possibilities. When individuals flourish through learning, it ultimately benefits society as a whole. Recognizing that the learning journey is a continuous adventure, we understand the importance of addressing each student's individual starting point. By providing stimulating and interactive tools and content, we nurture a love for learning that inspires, motivates, and equips every student for success. The technology that supports digital education serves not to create obstacles but to strengthen the connections between learners and educators, thereby positively influencing lives and shaping a brighter future. Through connecting, expanding, and enriching the educational experience with customized interactive content and tools, we strive to engage learners at their unique points of need. Our dedication to innovation and development ensures that we offer more effective and affordable educational solutions. As you delve into our wide array of products and services, you will uncover fresh approaches to making learning both accessible and enjoyable for all students, regardless of their backgrounds. Ultimately, we believe that fostering a supportive learning environment can transform lives and communities for the better.

ClassroomIO is a dynamic open source learning management system designed to enhance training, onboarding, and certification processes within various organizations. It offers a wide range of tools for course management, including capabilities for assessments, grading, attendance monitoring, and scorebook organization, which collectively enhance the educational experience for both teachers and students. Utilizing advanced AI technology, the platform assists educators in creating lesson outlines, planning lessons, and brainstorming ideas, allowing them to focus more on their primary teaching activities. Organizations can customize their dashboards to fit their specific requirements, resulting in a personalized learning journey. Additionally, a community-driven forum feature promotes engagement and collaboration among students and educators, fostering a culture of shared knowledge and support. With capabilities such as personalized landing page creation, efficient team management, automatic video transcription for easier searchability, and the option for students to download lessons as PDFs for offline use, ClassroomIO is equipped with an array of beneficial features. Moreover, the platform is committed to continuously improving user engagement through consistent updates and the addition of cutting-edge tools, ensuring it remains relevant in the ever-evolving landscape of education technology. This dedication to enhancement reflects a broader vision of creating a more interactive and effective learning environment for all users.

Cutting-edge technology emerging from doctoral research provides innovative connected care solutions for individuals living with dementia. Developed with contributions from those affected by the condition, DevaWorld encompasses over 15 therapeutic interventions and virtual activities tailored to daily living. Our methodology focuses on promoting human interaction instead of replacing it, fostering active participation from both caregivers and patients alike. With more than 15 evidence-backed therapeutic activities tailored to individual needs, the platform empowers users by boosting their confidence. DevaWorld is crafted to create a calming and meaningful environment that encourages social and environmental engagement, ultimately enhancing communication and mutual understanding. Specifically tailored for a residential community offering continuous memory care, it adheres to the highest standards of dementia therapy. A crucial element in the design was the integration of the caregiver-player relationship, as this collaborative experience plays a vital role in improving the mood and overall well-being of participants. By placing emphasis on this cooperative interaction, DevaWorld aspires to cultivate a nurturing environment that benefits both caregivers and those they care for, ensuring a holistic approach to dementia care. Ultimately, the platform seeks not only to assist but also to inspire joy and connection in daily interactions.

Behavioral health is an essential aspect of overall well-being, yet it is often overlooked and underappreciated. Mental health issues and substance use disorders impact around 970 million people worldwide, resulting in an economic toll that surpasses $1 trillion annually. Despite the worsening situation, progress in treatment and understanding has not advanced at the same rate as in other areas of medicine. Alarmingly, fewer than 50% of individuals with major depression, the most common mental health disorder, find relief through current treatment options. As awareness grows, there is a rising demand for services, yet the existing system is ill-prepared to handle the vast complexities associated with these needs. A substantial evidence gap poses significant challenges for research and innovation in this domain, stemming from difficulties such as complex disease mechanisms, a lack of measurable biomarkers, and disjointed approaches across institutions. Even after extensive research efforts, we still lack clarity on the most effective treatments for many behavioral health issues, highlighting an urgent need for renewed attention and funding in this area. Addressing these challenges is vital for enhancing the quality of life for millions grappling with these conditions and will ultimately lead to a healthier society overall.

IntelliSpace Portal 9.0 represents a groundbreaking visualization platform that incorporates more than 70 clinical applications, offering a unified solution that enhances both speed and efficiency while increasing diagnostic confidence, especially in the evaluation and management of intricate cases. With the aging global population, there is a rising incidence of neurodegenerative conditions that require ongoing monitoring for patients suffering from neurological disorders, which often present subtle alterations in brain structure that are challenging to detect. To tackle these complexities, IntelliSpace Portal 9.0 has unveiled a range of new and upgraded neuro applications, such as NeuroQuant®¹, LoBi, and CT Brain Perfusion, all crafted for rapid, objective, and uniform image evaluation. Furthermore, as awareness of pulmonary health grows, this platform provides a robust set of tools designed to effectively oversee pulmonary diseases from the first signs of detection to continuous follow-up, thereby striving to enhance patient outcomes. The inclusion of both neuro and pulmonary functionalities underscores the significance of IntelliSpace Portal 9.0 as an indispensable asset in the realm of contemporary medical imaging and diagnostics. Its innovative features not only streamline clinical workflows but also empower healthcare professionals to deliver more precise and timely interventions for their patients.

The microbiome is critically important in a range of diseases and health concerns. Kaleido is at the forefront of innovating a distinct approach to harness the microbiome's potential for effective patient treatments. The human microbiome consists of more than 30 trillion microbes, encompassing a wide variety of organisms such as bacteria, viruses, archaea, and fungi that reside both externally and internally within the body. In recent years, there has been an extraordinary increase in research examining how the microbiome affects human health, establishing connections to ailments like cardiovascular diseases, cancer, diabetes, Parkinson’s disease, and allergies. This complex network of microorganisms has been compared to a "newly discovered organ," underscoring its importance in human biology. Similar to how many human organs receive significant funding for therapies aimed at altering physiological processes, the microbiome stands as a largely uncharted domain in healthcare. By exploring this unexplored area, there is potential to reveal new therapeutic pathways that could significantly improve health outcomes for individuals. The quest to understand the microbiome better might be pivotal in revolutionizing modern medicine.

Established in 2016, Infervision is a leader in the realm of AI-powered medical technology, committed to improving healthcare operations and interdisciplinary services with cutting-edge artificial intelligence innovations. Their sophisticated AI solutions are crafted to support healthcare practitioners in a variety of functions, such as disease detection, diagnosis, intervention, treatment, patient management, and medical research. Notable among their products is InferRead CT Lung, which excels at identifying lung nodules in chest CT scans, while InferRead DR Chest is focused on uncovering chest abnormalities through X-ray imaging. Additionally, InferRead CT Coronary is specifically designed to detect coronary artery stenosis during coronary CT angiography, and InferRead CT Stroke is proficient in assessing brain hemorrhages via CT scans. The company also features InferRead CT Bone for identifying chest fractures in CT images, along with InferRead CT Pneumonia for diagnosing and managing pneumonia cases effectively. Their offerings extend further with InferOperate, which aids in 3D reconstruction for surgical procedures involving the thoracic, liver, and urological regions, as well as InferCare, a tool that enhances patient management and image follow-up. Furthermore, InferScholar serves as an AI-enhanced platform for advancing medical research, reinforcing Infervision's dedication to revolutionizing healthcare through its AI technology. This extensive collection of solutions firmly establishes Infervision as a crucial contributor to the advancement of modern medical practices, highlighting its role in shaping the future of healthcare delivery.

Apollo Medical Imaging Technology is an innovative software firm dedicated to improving medical imaging through cutting-edge image processing solutions designed for both clinical settings and research applications. Their flagship product, MIStar, is distinguished by its affordability and user-friendly interface, incorporating a vast array of advanced features and adaptable cross-modality solutions that meet the requirements of both clinicians and original equipment manufacturers. MIStar effectively supports multiple imaging modalities such as CT, MR, NM, and PET, and includes specialized components like CT Perfusion for analyzing strokes and tumors, DSC-MRI for stroke evaluations, and DCE-MRI for tumor diagnostics, along with DWI & ADC and DTI Fiber Tractography for comprehensive assessments. Furthermore, it features NM Renogram Analysis and Image Fusion functionalities, enhancing its utility as a holistic medical imaging tool. The software also guarantees efficient data handling and image input through DICOM networking, paired with a user-friendly clinical database that simplifies the anonymization and archiving of sensitive patient information. This comprehensive suite of capabilities establishes MIStar as an indispensable resource in contemporary medical imaging practices, making it a go-to solution for healthcare professionals striving for excellence in patient care and research.

Tempus AI, a leading health tech company located in Chicago, Illinois, is focused on revolutionizing patient care through the integration of advanced artificial intelligence and precision medicine. By harnessing data and AI, the firm aims to develop customized treatment strategies spanning various medical fields, including oncology, cardiology, radiology, and mental health. Their comprehensive platform merges genomic sequencing, clinical data, and AI-driven analytics, thereby providing healthcare professionals and researchers with vital insights. Tempus enhances patient understanding through a variety of testing methodologies, such as tissue and liquid biopsies, DNA and RNA sequencing, somatic and germline testing, as well as tumor-normal matched profiling and minimal residual disease monitoring. In addition, the company presents a fast and reliable platform for test ordering, acquiring patient insights, and integrating AI technologies into medical practice. Their innovative generative AI-enabled clinical assistant further streamlines access to patient insights, improving the efficiency of healthcare delivery. This dedication to leveraging state-of-the-art technology underscores Tempus AI's mission to elevate health outcomes and propel advancements in medical research. Ultimately, Tempus AI strives to be at the forefront of a transformative era in healthcare.

Improve patient outcomes by utilizing the sole objective, quantitative arterial analysis software that has been validated through histology and is based on CTA technology. This groundbreaking tool utilizes authentic histological data to identify the root causes of myocardial ischemia, aiding in the evaluation of risks associated with heart attacks and strokes. These serious medical incidents are frequently triggered by unstable, non-obstructive plaques in the arteries, which often go unnoticed and untreated. Conventional non-invasive diagnostic approaches are inadequate, as they fail to access the deeper layers of arterial walls where the early signs of heart disease appear. Elucid is harnessing cutting-edge scientific imaging along with artificial intelligence to provide swift, accurate, and non-invasive assessments, ultimately allowing for personalized treatment plans for cardiovascular issues and enhanced patient care. With this histology-validated software, you are equipped to analyze plaque characteristics and assess the likelihood of heart attacks and strokes with unparalleled accuracy. This thorough and objective assessment of arterial health enables healthcare professionals to develop individualized treatment strategies long before patients require hospitalization, thereby significantly elevating the standard of healthcare services. Furthermore, such proactive measures not only optimize treatment outcomes but also promote a more efficient healthcare system overall.

The incorporation of artificial intelligence is poised to transform the landscape of healthcare diagnostics. Utilizing AI and predictive analytics enables us to identify diseases at an early stage while improving the precision of diagnoses. Our innovative cloud-based AI platform seeks to make healthcare more accessible and cost-effective for all individuals. Endimension Technology, an emerging AI startup nurtured at IIT Bombay, focuses on creating sophisticated algorithms that detect abnormalities and illnesses through medical imaging. Our diverse team includes specialists in machine learning, software development, and healthcare professionals from prestigious institutions. We are committed to developing AI-powered healthcare solutions that aim to significantly reduce the chances of misdiagnosis among patients. Additionally, our technology is intended to ease the burden on radiologists and enhance the speed at which patients obtain their results, thus contributing to improved healthcare outcomes. By tapping into the capabilities of AI, we envisage a future where diagnostic procedures are not only more efficient but also more trustworthy. Our ultimate goal is to ensure that advancements in technology lead to enhanced patient care and overall health system improvements.

NeuroICH is a cutting-edge AI application specifically developed to detect cerebral hemorrhages, representing a significant leap forward in the care and treatment of individuals suffering from strokes. The importance of quick assessment and imaging interpretation cannot be overstated, as the adage "time is brain" emphasizes the critical need for prompt action. This pioneering technology is not only focused on saving lives but also on minimizing the lasting effects of strokes, which can include various disabilities. Recently, it has achieved FDA approval as a Software as a Medical Device (SaMD), which highlights its trustworthiness and efficacy in healthcare environments. With its introduction, NeuroICH aims to transform the landscape of stroke management, ultimately improving patient outcomes and enhancing the overall standard of care.

Diagnosis is the procedure that involves identifying the specific illness or condition responsible for a patient's symptoms and the results of medical tests. DDxHub, known as the Differential Diagnosis Hub, serves as a platform that differentiates a particular disease or condition from others that present with similar symptoms and test outcomes. DDxHub acts as a repository containing extensive descriptions of various diseases. It proves beneficial when aiming to pinpoint the correct diagnosis by allowing users to compare numerous potential conditions. Users have the option to upload their own definitions of diseases to the DDxHub database, enabling them to share this information with other users around the globe in return for disorder descriptions from the community. By joining the ranks of thousands of healthcare professionals and patients who appreciate the advantages of DDxHub’s differential diagnosis and disorder description sharing feature, you can enhance your diagnostic capabilities. Additionally, DDxHub serves as a valuable educational tool for medical students studying clinical therapeutics, providing a comprehensive resource for understanding various disorders.

NeuroQ distinguishes itself as a leading software solution for brain imaging analysis, providing an essential diagnostic tool that is versatile across multiple modalities and clinical settings. This all-encompassing application accommodates a variety of imaging methods such as FDG, Amyloid, SPECT, DaTscan, and Epilepsy, which significantly improves diagnostic accuracy when distinguishing between different medical conditions. Recognized as one of the most widely used quantitative tools in the nuanced diagnosis of dementia, NeuroQ goes beyond mere visual assessments, delivering vital and objective diagnostic insights. Its capability to evaluate metabolic levels in more than 240 predefined brain regions, in comparison to a normative database, enables the quantification of abnormalities and their statistical relevance. Tailored for analyzing human brain scans, NeuroQ meticulously computes mean pixel values within defined areas of interest, facilitating thorough comparisons with other brain images. This process ultimately aids in enhancing patient outcomes, making the software an indispensable resource for clinicians who require trustworthy data to guide their diagnostic and treatment strategies. Furthermore, by integrating cutting-edge technology with user-friendly features, NeuroQ empowers healthcare professionals to make informed decisions with confidence.

Examine challenges associated with plant emergence to guide replanting decisions effectively. Keep an eye out for weeds both prior to their germination and throughout the entire growing season to maximize the efficiency of herbicide application. Identify indicators of nutrient deficiencies that can signal shifts in crop health over time. Monitor for pests and diseases in crops to allow for precise pesticide use and protect overall yields. Recognize equipment malfunctions that could disrupt emergence and diminish yield potential. Evaluate moisture levels to ascertain whether crops are experiencing drought stress or excess watering. Leverage our sorting interface and crop progression maps to improve equipment management from planting through to harvesting. Enhance long-term productivity by identifying drainage and tiling problems before they adversely affect yields. Utilize advanced AI technology to pinpoint specific areas of crop stress, leading to more efficient scouting practices and providing growers with peace of mind. This cutting-edge AI cognitive decision-making tool has processed extensive crop imaging data across multiple seasons, showcasing its smart capabilities and ongoing enhancement. These innovations empower farmers to make well-informed choices that not only boost agricultural efficiency but also contribute to greater sustainability in their practices. By adopting these strategies, growers can optimize their operations and secure improved outcomes for future harvests.

Aiforia empowers both pathologists and researchers operating in preclinical and clinical lab environments by offering sophisticated deep learning and cloud-based solutions intended to optimize image analysis and improve operational workflows. By enabling researchers to uncover new disease biomarkers, helping R&D scientists to shorten the timelines for the creation of innovative therapies, and assisting pathologists in enhancing accuracy in cancer diagnoses, Aiforia utilizes its deep expertise to transform healthcare from the discovery stage all the way to diagnosis. For clinical pathology labs aiming to increase their productivity and improve diagnostic precision, Aiforia Clinical Suites provide a versatile suite of AI-driven diagnostic tools, advanced visualization capabilities, robust quality control protocols, and automated processes for pre- and post-screening. Moreover, we are currently developing tailored Suites specifically for some of the most prevalent cancers globally and have successfully obtained CE-IVD certification for our AI models targeting lung and breast cancer. As we continue to advance our technology, we remain committed to significantly enhancing patient outcomes while simultaneously optimizing laboratory operations. The potential impact of our innovations extends beyond immediate diagnostics, paving the way for a future of more personalized and effective healthcare solutions.

Cogmi is an innovative tool that leverages artificial intelligence to monitor mental efficiency, aiding both individuals and teams in synchronizing their tasks with inherent cognitive patterns to boost productivity and enhance overall well-being. This platform provides immediate evaluations of mental efficiency, monitoring aspects such as focus, memory, and energy fluctuations throughout the day. Users benefit from customized scheduling suggestions, insights powered by AI, and assessments of burnout risk, all aimed at maximizing performance while safeguarding against burnout. For individuals, Cogmi is accessible at no cost, while teams can take advantage of tailored dashboards, advanced analytics driven by AI, and coaching from cognitive experts. By promoting sustainable productivity, Cogmi encourages users to align their work habits with their brain's natural rhythms rather than fighting against them. It was developed to tackle the common problems of determining the best times to work and addressing issues related to fragmented concentration, ultimately striving to offer a more intelligent approach to understanding and improving mental efficiency. In doing so, Cogmi empowers users to harness their cognitive strengths for better outcomes in both professional and personal endeavors.

We develop cutting-edge AI solutions aimed at empowering healthcare professionals during pivotal moments in the medical workflow. From preventive screenings and early diagnosis to urgent interventions and managing disease outbreaks, our technology streamlines processes across the entire healthcare continuum. Collaborating with respected healthcare organizations and harnessing extensive data to refine our algorithms, we ensure our AI adheres to the highest international regulatory standards. Backed by thorough research in data science, our products are tailored to anticipate healthcare demands, particularly in complex scenarios. Our AI solutions are ready for immediate deployment, versatile enough to adapt to a wide range of environments and situations as required. They integrate effortlessly with your current technological infrastructure and can be tailored to work with your preferred devices. We offer clear and efficient options for deployment and scaling while prioritizing top-notch data security that meets industry benchmarks. Moreover, our dedicated team is here to assist you throughout every step of your AI implementation process, making certain you feel supported and confident. By incorporating our solutions, you have the opportunity to revolutionize healthcare delivery and significantly enhance patient outcomes, ultimately leading to a more effective and responsive healthcare system.

RelaxifyApp is a comprehensive platform, meticulously crafted by psychologists, that aims to enhance your cognitive, physical, social, and emotional well-being. Step into a serene atmosphere filled with gamified mental health tools that are designed to inspire and facilitate positive changes across these areas, ultimately leading to a greater sense of life satisfaction. Take part in engaging brain games that are specifically designed to help alleviate stress and reduce anxiety levels. Incorporating relaxation into your daily routine becomes easier with exercises focused on nurturing mental health. So, how does RelaxifyApp work? The platform utilizes free self-assessments and interactive games that promote self-awareness, encourage proactive engagement, and provide valuable insights into personal areas for improvement, along with actionable strategies for growth. The interactive games delve into various aspects, such as improving focus, enhancing emotional intelligence, recognizing and reprogramming negative thought patterns, and supporting overall physical health. Your experience with RelaxifyApp is designed to be fully supported, featuring continuous progress tracking. By joining a community of users who are noticing a considerable reduction in stress and anxiety, you can take proactive measures to avoid burnout through our free guided exercises and entertaining games, all specifically crafted to promote a healthier lifestyle. In this way, RelaxifyApp not only offers tools for immediate relief but also fosters long-term mental wellness.

Mahalo Health is a comprehensive digital health platform designed to accelerate the development of patient-centered digital health solutions and clinical trials. It offers an array of prebuilt modules that enable the rapid deployment of customizable white-label applications tailored to specific therapeutic areas. The platform is equipped with advanced data capabilities, which include a predictive health engine for anticipating diseases and diagnoses, a behavior modification engine that promotes healthy patient habits, and a notification system that guarantees prompt communication via push notifications, SMS, or emails. Mahalo Health is dedicated to upholding rigorous security and compliance standards, adhering to regulations like HIPAA, GCP, ISO27001, and GDPR. Its diverse service offerings span various therapeutic domains, such as diabetes management, cognitive health, cardiovascular care, musculoskeletal issues, mental well-being, oncology, rare diseases, and nonalcoholic steatohepatitis (NASH). Furthermore, Mahalo Health not only enhances patient engagement but also improves health outcomes by equipping healthcare providers with innovative digital tools and solutions that adapt to the evolving needs of their patients. This commitment to innovation ensures that healthcare delivery is both efficient and personalized.

Oncoustics is at the forefront of creating and implementing groundbreaking, patented AI technologies designed to deliver affordable, non-invasive surveillance, diagnostics, and treatment monitoring for diseases that currently present substantial clinical difficulties. The firm has introduced a suite of specialized applications aimed at different diseases and anatomical structures, which seamlessly integrate with any point-of-care ultrasound device, enabling healthcare providers, including physicians, nurses, and technicians, to use them as vital tools in primary care settings without the necessity for image analysis. By harnessing the power of AI, Oncoustics converts economical point-of-care ultrasound machines into advanced diagnostic tools that facilitate swift and cost-effective identification and monitoring of conditions related to the liver, prostate, kidney, breast, and thyroid. The diverse team behind Oncoustics comprises experts in AI, signal processing, radiology, hepatology, digital health, and ultrasound, fostering a holistic approach to healthcare advancement. Their focus on affordable point-of-care diagnostics and surveillance greatly improves patient outcomes through timely detection and consistent oversight, which are essential for effective disease management and enhanced overall health. Furthermore, Oncoustics is not merely tackling existing healthcare challenges but is also paving the way for a revolutionary shift in future disease management strategies, ensuring that the healthcare landscape evolves to meet the needs of patients more effectively. This forward-thinking approach positions Oncoustics as a key player in reshaping the future of medical diagnostics and patient care.

A significant portion, over 70%, of healthcare information resides in clinical documents like patient charts, discharge summaries, clinician notes, and reports, which enables our advanced Natural Language Processing and AI Engine to extract crucial concepts, attributes, and contextual details that enhance business insights, refine billing processes, evaluate and categorize patient risks, compute quality metrics, and collect patient sentiment and outcome information. By leveraging previously underutilized data sources, you can greatly advance your clinical research or business intelligence initiatives. Our extensive database encompasses thousands of clinical concepts, such as genomic biomarkers, symptoms, side effects, and medications, which facilitates the identification of disease characteristics and risk factors from clinical documents, thus improving patient stratification and raising the quality of care provided. Additionally, we prioritize the anonymity of data subjects by implementing effective document de-identification techniques, ensuring their privacy while still maintaining the data's utility. This dual focus on privacy and comprehensive data empowers healthcare organizations to make well-informed decisions grounded in the most extensive information available, ultimately leading to better patient outcomes and a more efficient healthcare system.

Artrya partners with clinics that focus on patients with chest pain to pioneer advanced AI-driven cardiovascular care models. This collaboration facilitates the integration of high-prognostic value plaque characteristics into the evaluation of coronary artery disease. In both emergency and primary care settings, swift assessments of chest pain patients become achievable. We foresee a future where heart attack occurrences within communities are drastically diminished. By leveraging AI insights from coronary computed tomography angiography (CCTA), healthcare providers can quickly categorize chest pain patients within minutes, based on the type and volume of arterial plaque identified. This innovative technology allows for the prompt detection of individuals with minimal or no coronary artery disease, ensuring that no concealed plaque characteristics are overlooked that could potentially lead to severe cardiac incidents in the future. Identifying early signs of a possible heart attack is of utmost importance. Furthermore, this method enables the effective identification of patients at risk who present with acute or atypical chest pain, guaranteeing they receive appropriate further evaluation and treatment. By adopting this proactive approach, not only are patient outcomes improved, but the overall health of the community is also enhanced, fostering a culture of preventive care. The ongoing commitment to integrating cutting-edge technology will continue to transform cardiovascular care for the better.

Recite Me Accessibility Toolbar stands out as a widely-used solution compliant with WCAG and ADA standards. It empowers users to modify and personalize the appearance of websites according to their individual requirements. This tool is especially beneficial for individuals facing visual, cognitive, mobility, and various other impairments. Additionally, Recite Me provides a complimentary Accessibility Checker, allowing users to assess the accessibility of their website effectively. This tool helps identify particular accessibility challenges, enabling website owners to address these issues and enhance overall accessibility. By utilizing Recite Me, users can create a more inclusive digital environment for everyone.

We explore health beyond conventional medical settings to better understand the impact of diseases on individuals. This comprehensive view of patient health uncovers new opportunities for business by introducing innovative ways to measure disease and overall wellness. By focusing on how illnesses influence everyday life, we can improve engagement with both healthcare providers and insurance payers, while also enhancing support for patients. Our goal is to create advanced algorithms that can predict the onset and progression of diseases, as well as identify key moments for timely interventions. Leveraging real digital data, we promote the benefits of our services. Our technology-enabled platform supports real-world research that incorporates unique behavioral data from daily life, offering advantages to clinical, medical affairs, and commercial sectors through Evidation's virtual research hub, Achievement. With customizable study designs and strategies for device integration, we streamline protocol management to ensure effective study execution. Moreover, we provide the option for sponsorship by either our team or your organization, fostering collaborative efforts tailored to specific needs. Ultimately, this approach aims to enhance the overall healthcare landscape by integrating innovative methodologies that benefit all involved stakeholders.

Cleerly is an innovative digital health company that is transforming the approach healthcare professionals take in addressing heart disease. Our cutting-edge clinical technologies empower clinicians to identify and accurately define atherosclerosis at its inception, facilitating the creation of personalized and potentially life-saving treatment options for patients throughout their healthcare experience. Instead of depending on indirect signs such as risk factors or symptoms, we prioritize direct measurements of atherosclerosis, which reflects the buildup of plaque in the heart's arteries. By harnessing our AI-powered digital care pathways, we deliver efficient, quick, and precise diagnostics and reporting that meet the needs of all parties involved, resulting in improved clinical outcomes and financial performance. Cleerly allows healthcare practitioners to go beyond traditional evaluations of heart disease by comprehensively analyzing, characterizing, and quantifying different types of plaque. This forward-thinking strategy not only aids clinicians in evaluating a patient's risk of a heart attack but also supports the development of effective treatment plans aimed at enhancing overall heart health. As a result, we contribute to better patient outcomes and elevate the quality of care provided in the healthcare system. By redefining the standards of heart disease management, Cleerly is setting a new benchmark for patient-focused healthcare.